transplante cardíaco: fase sildenafil
24 horas Diurno Noturno
N PAS PAD FC PAS PAD FC PAS PAD FC
1 114 76 86 114 76 89 114 76 80 2 135 83 86 135 83 90 135 83 77 3 114 75 121 115 75 123 114 76 117 4 113 77 88 115 79 90 111 75 87 5 111 72 91 111 72 94 110 74 84 6 116 81 92 117 83 93 112 77 90 7 125 80 93 129 82 99 117 74 81 8 115 78 94 116 80 98 116 77 91 9 113 77 104 108 73 106 126 88 97 10 112 75 91 120 83 97 105 68 85 11 96 63 114 100 68 112 88 55 117 12 122 73 100 125 77 113 119 70 85 13 124 71 91 131 76 99 112 64 79 14 108 74 96 106 74 99 110 76 91 15 102 66 86 103 66 87 100 65 84 16 110 67 88 112 71 93 104 57 80 17 104 73 103 104 73 108 103 73 92 18 114 78 108 113 78 113 117 78 100 19 120 79 91 119 80 91 122 78 92 20 112 73 89 118 79 91 102 62 86 21 117 77 89 118 79 93 113 74 81 22 115 65 107 116 68 106 108 54 108 114,2 74,2 95,8 115,7 76,1 99,3 111,7 71,5 90,2 ± 8,2 5,3 9,8 8,9 5,1 9,7 9,7 8,8 11,4
N, número de pacientes; PAS, pressão arterial sistólica (mmHg); PAD, pressão arterial diastólica (mmHg); FC, frequência cardíaca (bpm); média; ± desvio padrão.
VERIDIANA MORAES D`AVILA DAMAS GARLIPP 47
VERIDIANA MORAES D`AVILA DAMAS GARLIPP 48
1 Maraztz PR, Tobin JN, Wassertheil-Smoller S. The relationship between left
ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation 1998;77:607-12.
2 Bellotti P, Badano PL, Acquarone N et al. Speciality-releted differences in
the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. Eur Heart J 2001;22:596-604.
3 Barreto A; Bocchi E. Insuficiência Cardíaca. São Paulo, Segmento,
2003.315p.
4 Zoll J, N’Guessan B, Ribera F, et al. Preserved response of mitochrondial
function to short-term endurance training in skeletal muscle of heart transplant recipients. J Am Coll Cardiol 2003;42:126-32.
5 Lucini D, Milani RV, Ventura HO, et al. Study of arterial and autonomic
effects of cyclosporine in humans. Hypertension 2000;35:1258-63.
6 Salyer J, Jewell D, Quigg R. Predictors of early post-cardiac transplant
exercise capacity. J Cardiopulmonary Rehabil 1999;19:381-388.
7 Bacal F, Pires PV, Moreira LF, et al. Normalization of right ventricular
performance and remodeling evaluated by magnetic resonance imaging at late follow-up of heart transplantation: relationship between function, exercise capacity and pulmonary vascular resistance. J Heart Lung Transplant. 2005; 24:2031-2036.
8 Kavanagh T, Mertens D, Shepard R et al. Long-term cardiorespiratory
results of exercise training following cardiac transplantation. Am J Cardiol 2003;91:190-194.
VERIDIANA MORAES D`AVILA DAMAS GARLIPP 49
9 Mettauer B, Lampert E, Charloux A, et al. Lung membrane diffusing
capacity, heart failure, and heart transplantation. Am J Cardiol 1999; 83:62- 67.
10 Marconi C, Marzorati M. Exercise after heart transplantation. Eur J Appl
Physiol 2003; 90:250-259.
11 Biring MS, Fournier M, Ross DJ, Lewis MI. Cellular adaptations of skeletal
muscles to cyclosporine. J Appl Physiol. 1998; 84(6):1967-1975.
12 Braith WR, Limacher MC, Leggett SH, et al. Skeletal Muscle Strength in
hearrt transplant recipients. J Heart Lung Transplant 1993;12:1018-1023.
13 Pierre GL, Magyari PM, Aranda JM Jr, et al. Effect of heart transplantation
on skeletal muscle metabolic enzyme reserve and fiber type in end-stage heart failure patients. Clin Transplant 2007;21(1):94-100.
14 Beckers F, Ramaekers D, Cleemput J et al. Association between
restoration of autonomic modulation in the native sinus node of hemodynamic improvement after cardiac transplantation. Transplantation 2002;73:1614-1620.
15 Squires R. Exercise training after cardiac transplantation. Medicine and
Science in Sports and Medicine 1991;23(8):686-694.
16 Überfuhr P, Frey A, Fuchs A et al. Signs of vagal reinnervation 4 years
after transplantation in spectra of heart rate variability. European Journal of Cardio-thoracic Surgery 1997;12:907-912.
17 Kao AC, Van Trigt PIII, Shaeffer-McCall GS, et al. Heart failure/cardiac
transplantation/artificial heart disease: central transplant and peripherial limitations to upright exercise in untrained cardiac transplant recipients. Circulation 1994;89:2605-2615.
VERIDIANA MORAES D`AVILA DAMAS GARLIPP 50
18 Patel AR, Kuvin JT, DeNofrio D, et al. Peripheral vascular endothelial
function correlates with exercise capacity in cardiac transplant recipients. The Amer J of Cardiol 2003;91:897-899.
19 Chowdhary S, Harrington D, Bonser R et al. Chronotropic effects of nitric
oxide in the denervated humam heart. Journal of Physiology 2002;541:645-651.
20 Schmidt A, Pleiner J, Bayerle-Eder M, et al. Regular physical exercise
improves endothelial function in heart transplant recipients. Clin Transplant 2002;16:137-143.
21 Gessler t, Seeger W, Schmehi T. Inhaled Prostanoids in the therapy of
pulmonary hypertension. J Aerosol Med 2008; 16.
22 Gryglewski RJ, Chlopicki S, Uracz W, Marcinkiewics E. Significance of
endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. Med Sci Monit 2001;7(1):1-16.
23 Gwozdz P, Lukasz D, Kozlovski V, et al. Prostacyclin, but not nitric oxide,
is the major mediator of acetylcholine-induced vasodilatation in the isolated mouse heart. Pharmac Reports 2007;59:545-552.
24 Li Y, Chiang CW, Yeh HC, et al. Structures of prostacyclin synthase and its
complexes with substrate analog and inhibitor reveal a ligand-specific heme conformation change. JBC 2007;283(5):2917-2926.
25 Fischer D, Rossa S, Landmesses U, et al. Endothelial dysfunction in
patient with chronic heart failure is dependently associated with increased incidence of hospitalization, cardiac transplantation, or death. Eur Heart J 2005;26(1):65-69.
VERIDIANA MORAES D`AVILA DAMAS GARLIPP 51
26 Doutreleau S, Piquard F, Lonsdorfer E, et al. Improving exercise capacity,
6 wk training tends to reduce cisculating entothelin after heart transplantation. Clin Transplant 2004;18:672-675.
27 Lindelfeld J, Page RL, Zolty R, et al. DRug therapy in the heart transplant
recipient. Parrt III: common medical problems. Circulation 2005;111:113- 117.
28 Schwietzer GK, Hartmann A, Kober G, et al. Chronic angiotensin-
converting enzyme inhibition may improve sodium excretion in cardiac transplant hypertension. Transplantation 1995;59:999-1004.
29 Taegtemeyer A, Crook A, Barton P, Banner N. Reduce Incidence of
hypertension after heterotopic cardiac transplantation compared with orthotopic cardiac transplantation: Evidence that excision of the native heart contributes to post-transplant hypertension. JACC 2004;44(6):1255- 1260.
30 Eisen H. Hypertension in heart transplant recipients: more than just
cyclosporine. JACC 2003;41(3):433-434.
31 Khot U, Binkley P, Haas G, et al. Prospective study of the circadian pattern
of blood pressure after heart transplantation. J Heart and Lung Transplant 1996;15:350-359.
32 American College of Sports Medicine. ACSM Stand position on exercise
and hypertension. Med Sci Sports Exerc 2004;36:533-553.
33 Wallace JP, Bogle PG, King BA, et al. A comparison of 24-h average blood
pressures and blood pressure load following exercise. AJH 1997;10:728- 734.
VERIDIANA MORAES D`AVILA DAMAS GARLIPP 52
34 Pierdomenico SD, Lapenna D, Guglielmi MD, et al. Arterial disease in
dipper and nondipper hypertensive patients. AJH 1997;10:511-518.
35 Schofield RS, Edwards DG, Schuler BT, et al. Vascular effects of sildenafil
in hypertensive cardiac transplant recipients. Am J Hypertens 2003; 16:874-877.
36 Zusman RM, Morales A, Glasser DB, et al. Overal cardiovascular profile of
sildenafil citrate. Am J Cardiol 1999;83:35C-44C.
37 Vallance P, Chan N. Endothelial function and nitric oxide: clinical
relevance. Heart 2001; 85:342-9.
38 Beavo JA. Cyclic nucleotide phosphodiesterase: functional implications of
multiple isoforms. Physiol Rev 1995; 75:725-48.
39 Ballard AS, Gingell CJ, Tang K, et al. Effects of sildenafil citrate on the
relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic phosphodiesterase isozyme. J Urol 1998;159:2164-2171.
40 Kirby M, Jackson G, Simonsen U. Endothelial dysfunction links erectile
dysfunction to heart disease. Int J Clin Pract 2005;59(2):225-229.
41 Guimarães GV, Belloti G, Bacal F, et al. Pode o teste ergoespirométrico de
caminhada de 6 minutos ser representativo das atividades habituais de pacientes com insuficiência cardíaca? Arq Bras Cardiol 2002;78(6):553- 556.
42 Patterson JÁ, Naughton J, Pietras RJ. Treadmill exercise in assessment of
functional capacity of patients with severe left ventricular disease. Am J Cardiol 1972;30:757-762.
VERIDIANA MORAES D`AVILA DAMAS GARLIPP 53
43 Jackson G, Benjamin N, Jackson N, Allen MJ. Effects of sildenafil citrate
on human hemodynamics Am J Cardiol 1999; 83:13C-20C.
44 Bocchi EA, Guimaraes G, Mocelin A, et al. Sildenafil effects on exercise,
neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction. Circulation 2002; 106:1097- 1103.
45 Idema RN, Van den Meiracker AH, Balk AH, et al. Abnormal diurnal
variation of blood pressure, cardiac output, and vascular resistance in cardiac transplant recipients. Circulation 1994;90:2797-2803.
46 Khot UN, Binkley PF, Haas GJ, et al. Prospective study of the circadian
pattern of blood pressure after heart transplantation. J Heart Lung
Transplant. 1996;15:350-359.
47 Lim DS, Mooradian SJ, Goldberg CS, et al. Effect of oral l-arginine on
oxidant stress, endothelial dysfunction, and systemic arterial pressure in young cardiac transplant recipients. Am J Cardiol 2004;94:823-831.
48 Rees DD, Palmer RMJ, Schulz R, et al. Characterization of three inhibitors
of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101:746-752.
49 Medina P, Segarra G, Vila JM, et al. Effects of sildenafil citrate on human
penile blood vessels. Urology 2000; 56:539-543.
50 Katz SD, Balidemaj K, Homma S, et al. Acute type 5 phosphodiesterase
inhibition with sildenafil citrate enhances flow-mediated vasodilation in patients with chronci heart failure. J Am Coll Cardiol 2000; 36:845-851.
VERIDIANA MORAES D`AVILA DAMAS GARLIPP 54
51 Karppanen H. Minerals and blood pressure. Annals of Medicine
1991;23:299-305.
52 Nadler JL, McKay M, Campese V, et al. Evidende that prostacyclin
modulates the vascular actions of calcium in man. J Clin Invest 1986;77(4):1278-1284.
53 Nadler JL, Goodson S, Rude RK. Evidence that prostacyclin mediates the
vascular actin of magnesium in humans. Hypert 1987;9(4):379-383.
54 Salonen JT. Dietary fats, antioxidants and blood pressure. Annals of
Medicine 1991;23:295-2998.
55 Arnaud J, Bost M, Vitoux D, et al. Effect of low dose antioxidant vitamin
and trace element supplementation on the urinary concentrations of thromboxane and prostacyclin metabolites. J Am Coll Nutr 2007;26(5):405-411.
56 Zwissler B, Welte M, Messmer K. Effects of inhaled prostacyclin as
compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction. J Cardiothorac Vasc Anesth 1995;9(3):283-289.
57 Ruiz MJ, Escribano P, Delgado JF, et al. Efficacy of sildenafil as a rescue
therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience. J Heart Lung Transplant 2006;25(11):1353-1357.
58 Ogoh S, Brothers RM, Barnes Q, e al. Effects of changes in central blood
volume on carotid-vasomotor baroreflex sensitivity at rest and during exercise. J Appl Physiol 2006 Mar 30
VERIDIANA MORAES D`AVILA DAMAS GARLIPP 55
59 Haywood GA, Counihan PJ, Sneddon JF, et al. Increased renal and
forearm vasoconstriction in response to exercise after heart transplantation. Be Heart J 1993;70:247-251.
60 Wallace JP, Bogle PG, King BA, et al. A Comparison of 24-h average
blood pressure and blood pressure load following exercise. Am J
Hypertens 1997;10:728-734.
61 Brownley KA, West SG, Hinderliter AL, Light KC. Acute aerobic exercise
reduces ambulatory blood pressure in borderline hypertensive men and women. Am J Hypertens. 1996;9(3):200-206.
62 Taylor-Tolbert NS, Dengel DR, Brown MD, et al. Ambulatory blood
pressure after acute exercise in older men with essential hypertension. Am
J Hypertens. 2000;13:44-51.
63 Jackson G. Hemodynamic and exercise effects of phosphodiesterase 5
inhibitors. Am J Cardiol 2005;96(suppl):32M-36M.
64 Herrmann HC, Chang G, Klugherz BD, Mahoney PD. Hemodynamic
effects of sildenafil citrate in men with severe coronary artery disease. N
Engl J Med 2000; 342:1622-1626.
65 Carson III CC. Cardiac safety in clinical trials of phosphodiesterase 5
inhibitors. Am J Cadiol 2005;96[suppl]:37M-41M.
66 Pescatello LS, Franklin BA, Fagard R, et al. American College of Sports
Medicine American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc. 2004 Mar;36(3):533-553.
67 Hallwill JR. Mechanisms and clinical implications of post exercise
VERIDIANA MORAES D`AVILA DAMAS GARLIPP 56
68 Chandler MP, DiCarlo SE. Sinoaortic denervation prevents postexercise
reductions in arterial pressure and cardiac sympathetic tonus. Am J
Physiol. 1997; 273:H2738-2745.
69 Chandler MP, Rodenbaugh DW, DiCarlo SE. Arterial baroreflex resetting
mediates postexercise reductions in arterial pressure and heart rate. Am J
Physiol. 1998; 275:H1627-1634.
70 Lim DS, Mooradian SJ, Goldberg CS, et al. Effect of oral L-arginina on
oxidant stress, endothelial dysfunction, and systemic arterial pressure im young cardiac transplant recipients. Am J Cardio 2004;94:828-831.
71 Holm T, Aukrust P, Aagaard E, et al. Hypertension in relation to nitric
oxide, asymetric dimethylarginine, and infammation: different patterns in heart transplant recipients and individuals with essential hypertension. Transplant 2002;74:1395-1400.
72 Parra DA, Lim DS, Buller CL, Charpie JR. Endothelial dysfunction and
circadian blood pressure rhythmicity in yong heart transplant recipients. Pediatr Cardiol 2007,28(1):1-7.
73 Ramzy D, Rao V, Mallidi H, et al. Cardiac allograft preservation using
donor-shed blood supplemented with L-arginina. J Heart Lung Transplant 2005;24(10):1665-1672.
74 Schmidt A, Pleiner J, Bayerle-Eder M, et al. Regular physical exercise
improves endothelial function in heart transplant recipients. Clin
Transplant. 2002; 16:137-141.
75 Kotsis VT, Stabouli SV, Pitiriga VCh, et al. Impact of cardiac
transplantation in 24 hours circadian blood pressure and heart rate profile.
VERIDIANA MORAES D`AVILA DAMAS GARLIPP 57
76. Khot UN, Binkley PF, Haas GJ, Starling RC. Prospective study of the
circadian pattern of blood pressure after heart transplantation. J Heart
Lung Transplant. 1996 Apr;15(4):350-359.
77 Bocchi EA, Vilella de Moraes AV, Esteves-Filho A, et al. L-arginine
reduces heart rate and improves hemodynamics in severe congestive heart failure. Clin Cardiol 2000; 23:205-210.
78 Gilbert EM, Eiswirth CC, Mealey PC, et al. Beta-adrenergic supersensitivity
of the transplanted human heart is presynaptic in origin. Circulation 1989; 79:344-349.
79 Zusman RM, Prisant LM, Brawn MJ. Effect of on blood pressure and heart
rate in men with erectile dysfunction taking concomitant antihypertensive medication. J Hypertension 2000; 18:1865-1869.
80 Andreassen AK, Kvernebo K, Jorgensen B, et al. Exercise capacity in
heart transplant recipients: relation to impaired endothelium-dependent vasodilation of the peripheral microcirculation. Am Heart J. 1998; 136:320- 328.
81 Kobashigawa JA, Leaf DA, Lee N,et al. A controlled trial of exercise
rehabilitation after heart transplantation. N Engl J Med 1999; 340:320-328.
82 Mulligan T, Sheehan H, Hanrahan J. Sexual function after heart
transplantation. J Heart Transplant 1991; 10:125-128.
83 Takimoto E, Champion HC, Li M, et al. Chronic inhibition of cyclic GMP
phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat